281
Views
7
CrossRef citations to date
0
Altmetric
Original Research

A Split-Face Study Assessing the Clinical Benefit, Tolerability and Subject Satisfaction of a Dermocosmetic in Subjects with Rosacea Associated with Erythema and Sensitive Skin

ORCID Icon, ORCID Icon, , ORCID Icon, , & ORCID Icon show all
Pages 751-758 | Published online: 05 Oct 2020

References

  • Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78(1):148–155.29089180
  • Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176(2):431–438. doi:10.1111/bjd.1512227718519
  • Thiboutot D, Anderson R, Cook-Bolden F, et al. Standard management options for rosacea: the 2019 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2020;82(6):1501–1510. doi:10.1016/j.jaad.2020.01.07732035944
  • Fonseca GP, Brenner FM, Muller Cde S, Wojcik AL. Nailfold capillaroscopy as a diagnostic and prognostic method in rosacea. An Bras Dermatol. 2011;86(1):87–90. doi:10.1590/S0365-0596201100010001121437527
  • Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51(3):327–41; quiz 42–4. doi:10.1016/j.jaad.2004.03.030
  • Powell FC. The histopathology of rosacea: ‘where’s the beef?’ Dermatology. 2004;209(3):173–174. doi:10.1159/00007988415459527
  • Kligman AM. An experimental critique on the state of knowledge of rosacea. J Cosmet Dermatol. 2006;5(1):77–80. doi:10.1111/j.1473-2165.2006.00228.x17173577
  • Quarterman MJ, Johnson DW, Abele DC, Lesher JL Jr, Hull DS, Davis LS. Ocular rosacea: signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol. 1997;133(1):49–54. doi:10.1001/archderm.1997.038903700550099006372
  • Rosen T, Stone MS. Acne rosacea in blacks. J Am Acad Dermatol. 1987;17(1):70–73. doi:10.1016/S0190-9622(87)70173-X2956299
  • Alexis AF. Rosacea in patients with skin of color: uncommon but not rare. Cutis. 2010;86(2):60–62.20919596
  • Tidman MJ. Improving the management of rosacea in primary care. Practitioner. 2014;258(1775):27–30, 3.
  • Dirschka T, Micali G, Papadopoulos L, Tan J, Layton A, Moore S. Perceptions on the psychological impact of facial erythema associated with rosacea: results of International Survey. Dermatol Ther (Heidelb). 2015;5(2):117–127. doi:10.1007/s13555-015-0077-226022994
  • Cardwell LA, Nyckowski T, Uwakwe LN, Feldman SR. Coping mechanisms and resources for patients suffering from rosacea. Dermatol Clin. 2018;36(2):171–174. doi:10.1016/j.det.2017.11.01329499801
  • Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Patients with rosacea have increased risk of depression and anxiety disorders: a Danish Nationwide Cohort Study. Dermatology. 2016;232(2):208–213. doi:10.1159/00044408226954304
  • Halioua B, Cribier B, Frey M, Tan J. Feelings of stigmatization in patients with rosacea. J Eur Acad Dermatol Venereol. 2017;31(1):163–168. doi:10.1111/jdv.1374827323701
  • Schaller M, Almeida LMC, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol. 2020;182(5):1269–1276.31392722
  • Ahn CS, Huang WW. Rosacea pathogenesis. Dermatol Clin. 2018;36(2):81–86. doi:10.1016/j.det.2017.11.00129499802
  • Nusgens BV. Hyaluronic acid and extracellular matrix: a primitive molecule? Ann Dermatol Venereol. 2010;137(Suppl 1):S3–S8. doi:10.1016/S0151-9638(10)70002-820435253
  • Burke KE. Mechanisms of aging and development-a new understanding of environmental damage to the skin and prevention with topical antioxidants. Mech Ageing Dev. 2018;172:123–130. doi:10.1016/j.mad.2017.12.00329287765
  • Hughes MC, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med. 2013;158(11):781–790. doi:10.7326/0003-4819-158-11-201306040-0000223732711
  • Nonotte I, Montastier C, Boisnic S, Branchet-Gumila MC, Breton L. Inhibitory effect of Lucas spring water on substance P induced inflammation in organ culture of human skin. NouvDermatol. 1998;17:2–11.
  • Moyal D, Tricaud C, Pham DM, Ngyen QL. P2619 efficacy of a spa water in preventing UVA-induced catalase degradation. J Am Acad Dermatol. 2006;54(3).
  • Mascarenhas NL, Wang Z, Chang YL, Di Nardo A. TRPV4 mediates mast cell activation in cathelicidin-induced rosacea inflammation. J Invest Dermatol. 2017;137(4):972–975. doi:10.1016/j.jid.2016.10.04627908695
  • Buddenkotte J, Steinhoff M. Recent advances in understanding and managing rosacea. F1000Res. 2018;7:1885. doi:10.12688/f1000research.16537.1
  • Tacheau C, Weisgerber F, Fagot D, et al. Vichy Thermal Spring Water (VTSW), a cosmetic ingredient of potential interest in the frame of skin ageing exposome: an in vitro study. Int J Cosmet Sci. 2018;40(4):377–387. doi:10.1111/ics.1247029879297
  • Tan J, Spada J, Orlandi C, et al. Vichy mineralizing water with hyaluronic acid is effective and well tolerated as an adjunct to the management of various dermatoses and after esthetic procedures. J Cosmet Dermatol. 2020;19(3):682–688. doi:10.1111/jocd.1322931793738
  • Caberlotto E, Cornillon C, Njikeu S, Monot M, Vicic M, Flament F. Synchronized in vivo measurements of skin hydration and trans-epidermal water loss. Exploring their mutual influences. Int J Cosmet Sci. 2019;41(5):437–442. doi:10.1111/ics.1255631310331
  • Ye L, Wang Z, Li Z, Lv C, Man MQ. Validation of GPSkin barrier® for assessing epidermal permeability barrier function and stratum corneum hydration in humans. Skin Res Technol. 2019;25(1):25–29. doi:10.1111/srt.1259029863296
  • Cointereau-Chardon S, Caberlotto E, Vicic M, Flament F. Self-recording the skin hydration and trans-epidermal water loss parameters: a pilot study. Skin Res Technol. 2020. doi:10.1111/srt.12862
  • Frosch PJ, Frosch PJ, Kligman AM. A method for appraising the stinging capacity of topically applied substances. J Soc Cosmet Chem. 1977;28:197–209.
  • Schlesinger TE, Powell CR. Efficacy and tolerability of low molecular weight hyaluronic acid sodium salt 0.2% cream in rosacea. J Drugs Dermatol. 2013;12(6):664–667.23839183
  • Sahni DR, Feldman SR, Taylor SL. Ivermectin 1% (CD5024) for the treatment of rosacea. Expert Opin Pharmacother. 2018;19(5):511–516. doi:10.1080/14656566.2018.144756229544355